Andreas Caduff has been a driving force in the development of non-invasive and contextualized physiological monitoring. He was serving as CTO of Solianis where he orchestrated the development of non-invasive glucose monitoring. He then founded Biovotion and served for 7 years as CEO, offering a state-of-the-art user-centric, analytics driven ecosystem, powered by medical wearable technology. Biovotion received several international awards and high-caliber endorsements for its innovations, including an award from the XPrize Foundation. Biovotion was acquired in 2019.

Today he is a health tech leader at Amazon, working at the interface of agent supported medical technology, physiological monitoring and data science, towards a more holistic view of health.